Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Novel ophthalmic agents disclosed by the University of Michigan

May 25, 2005

Update on the therapeutic benefits of anecortave in AMD

May 25, 2005

Clinical evidence of the benefits of bevacizumab in patients with eye disorders

May 24, 2005

Phase II data support the use of squalamine lactate in AMD

May 23, 2005

Novel integrin inhibitor delivered via sustained-release implant tested for treating eye diseases

May 20, 2005

HDP-P-5F2'DU: A novel intravitreally injectable, crystalline prodrug of 5-flourouracil

May 20, 2005

Alcon presents data on novel VEGFR inhibitors for CNV

May 19, 2005

Linomide analogue Lin-05 demonstrates potent antiangiogenic activity

May 19, 2005

MB-500 promotes corneal wound healing

May 18, 2005

SCR-011, a therapeutic candidate for ocular neovascularization

May 18, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...